Saturday, February 22, 2020


February 2020 - The FDA has granted CooperVision approval for its new Biofinity toric multifocal contact lenses. The product combines the optical designs of CooperVision’s Biofinity toric—the most prescribed toric lens on the market1—and Biofinity multifocal to provide patients with astigmatism and presbyopia vision correction. The company plans to make the lenses available to US eye care professionals later this year, followed by other markets. Lens parameters and other details regarding Biofinity toric multifocal will be made public in the coming months.
This is a huge deal!  Biofinity toric is considered the most stable toric contact lens.  And Biofinity Multifocal provides low, medium, and high adds in either a center distance or center near design.  This lens should be a game changer. 

No comments:

Post a Comment

Leave a Comment or Question: